Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s ; volume:10 ; number:1 ; day:8 ; month:9 ; year:2022 ; pages:1-25 ; date:12.2022
Acta Neuropathologica Communications ; 10, Heft 1 (8.9.2022), 1-25, 12.2022

Creator: Toomey, Christina E.
Heywood, Wendy E.
Evans, James R.
Lachica, Joanne
Pressey, Sarah N.
Foti, Sandrine C.
Shahrani, Mesfer Al
D’Sa, Karishma
Hargreaves, Iain P.
Heales, Simon
Orford, Michael
Troakes, Claire
Attems, Johannes
Gelpi, Ellen
Palkovits, Miklos
Lashley, Tammaryn
Gentleman, Steve M.
Revesz, Tamas
Mills, Kevin
Gandhi, Sonia

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-022-01424-6

URN: urn:nbn:de:101:1-2022112521071827815891

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 09.06.2032, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Toomey, Christina E.
Heywood, Wendy E.
Evans, James R.
Lachica, Joanne
Pressey, Sarah N.
Foti, Sandrine C.
Shahrani, Mesfer Al
D’Sa, Karishma
Hargreaves, Iain P.
Heales, Simon
Orford, Michael
Troakes, Claire
Attems, Johannes
Gelpi, Ellen
Palkovits, Miklos
Lashley, Tammaryn
Gentleman, Steve M.
Revesz, Tamas
Mills, Kevin
Gandhi, Sonia
SpringerLink (Online service)

Other Objects (12)

Mitochondrial dysfunction in Parkinson’s disease

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment

Treatment Options for Urogenital Dysfunction in Parkinson’s Disease

Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment

Treatment Options for Urogenital Dysfunction in Parkinson’s Disease

Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment

Treatment Options for Urogenital Dysfunction in Parkinson’s Disease

Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Mitochondrial dysfunction in Parkinson’s disease

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment

Treatment Options for Urogenital Dysfunction in Parkinson’s Disease

Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment

Treatment Options for Urogenital Dysfunction in Parkinson’s Disease

Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease

Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease

Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease

Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment

Treatment Options for Urogenital Dysfunction in Parkinson’s Disease

Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease

Related objects

Reset password